Skip to content

Clinical trials

Phase 2/3 Metabolic Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Phase 2/3 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20082
20171
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Joslin Diabetes Center3
Brigham and Women's Hospital1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Northwell Health1
Rutgers University1
University of Massachusetts, Worcester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome8
Inflammation4
Diabetes Mellitus, Type 22
Obesity2
Coronary Artery Disease1
Diabetes, Gestational1
Overweight1
Paraplegia1
Quadriplegia1
Spinal Cord Injuries1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.